ArticleJournal of translational medicine2024

SULT2B1: a novel therapeutic target in colorectal cancer via modulation of AKT/PKM2-mediated glycolysis and proliferation.

Jianxing Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.